Daily spirometry in an acute exacerbation of adult cystic fibrosis patients

被引：3

作者：

Stephen, Michael J. ^{[1
]}

Long, Alex ^{[2
]}

Bonsall, Chad ^{[3
]}

Hoag, Jeffrey B. ^{[1
]}

Shah, Smita ^{[4
]}

Bisberg, Dorothy ^{[4
]}

Holsclaw, Douglas ^{[3
]}

Varlotta, Laurie ^{[5
]}

Fiel, Stan ^{[6
]}

Du, Doantrang ^{[7
]}

Zanni, Robert ^{[7
]}

Hadjiliadis, Denis ^{[3
]}

机构：

[1] Drexel Univ, Sch Med, Div Pulm & Crit Care, Philadelphia, PA USA

[2] Drexel Univ, Sch Publ Hlth, Philadelphia, PA USA

[3] Univ Penn, Div Pulm & Crit Care, Philadelphia, PA USA

[4] Pediat Specialty Ctr, St Barnabas Med Ctr, Barnabas Hlth Med Grp, W Orange, NJ USA

[5] St Christophers Hosp Children, Philadelphia, PA USA

[6] Atlantic Hlth Syst, Morristown, NJ USA

[7] Monmouth Med Ctr, Long Branch, NJ USA

来源：

CHRONIC RESPIRATORY DISEASE | 2018年 / 15卷 / 03期

关键词：

Cystic fibrosis; acute exacerbation; home spirometry; CFQ-R; intravenous antibiotics; QUALITY-OF-LIFE; PULMONARY EXACERBATIONS; RESPIRATORY EXACERBATIONS; ANTIBIOTIC-TREATMENT; MORTALITY; OUTCOMES;

D O I：

10.1177/1479972317743756

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

To help answer the question of length of intravenous antibiotics during an acute exacerbation of cystic fibrosis (CF), we had subjects to follow daily home spirometry while on intravenous antibiotics. CF patients, 18 and older, with an acute exacerbation requiring intravenous antibiotics had a daily FEV1. The average time to a 10% increase over their initial sick FEV1 was calculated, as well as the time to a new baseline. A total of 25 subjects completed the study. Ten of the 25 subjects did not have a sustainable 10% increase in FEV1. Of the 15 subjects with a sustainable 10% increase in FEV1, it took 5.2 days (+/- 4.5) after day 1, while a new baseline was achieved on average at 6.6 days (+/- 4.8) after day 1. Given the wide range of time to a 10% improvement and new baseline, it is recommended there should be flexibility in length of intravenous antibiotics in CF, not by a preset number.

引用

页码：258 / 264

页数：7

共 50 条

[1] DAILY HOME SPIROMETRY USE IN CF PATIENTS WITH AN ACUTE EXACERBATION
Stephen, M. J.
Chad, B.
Hoag, J. B.
Holsclaw, D.
Zanni, R. L.
Varlotta, L.
Fiel, S.
Hadjiliadis, D.
PEDIATRIC PULMONOLOGY, 2014, 49 : 364 - 364
[2] DAILY HOME SPIROMETRY USE IN CF PATIENTS WITH AN ACUTE EXACERBATION
Stephen, M. J.
Hadjiliadis, D.
Hoag, J. B.
Holsclaw, D.
Fiel, S.
Varlotta, L.
Zanni, R. L.
Bonsall, C.
PEDIATRIC PULMONOLOGY, 2015, 50 : 357 - 358
[3] Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation
Kidd, James M.
Sakon, Colleen M.
Oleksiuk, Louise-Marie
Cies, Jeffrey J.
Pettit, Rebecca S.
Nicolau, David P.
Kuti, Joseph L.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
[4] IMPACT OF ROUTINE SPIROMETRY IN THE FREQUENCY OF ACUTE PULMONARY EXACERBATION DIAGNOSIS IN CYSTIC FIBROSIS.
Barboza de Aquino Mota, Carolina Silva
da Silva Filho, Luiz Vicente Ribeiro F.
Rodrigues, Joaquim Carlos
PEDIATRIC PULMONOLOGY, 2016, 51 : S50 - S50
[5] Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis
Carter, Suzanne C.
Franciosi, Alessandro N.
O'Shea, Kate M.
O'Carroll, Orla M.
Sharma, Ashutosh
Bell, Aoife
Keogan, Brian
O'Reilly, Paul
Coughlan, Suzie
Law, Sheonagh M.
Gray, Robert D.
Hisert, Katherine B.
Singh, Pradeep K.
Cooke, Gordon
Grogan, Brenda
De Gascun, Cillian F.
Gallagher, Charles G.
Nicholson, Trevor T.
Quon, Bradley S.
McKone, Edward F.
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (11) : 1818 - 1826
[6] Phenotypes in Patients with Cystic Fibrosis at the Time of Acute Exacerbation
Carter, S. C.
Keogan, B.
O'Reilly, P.
Coughlan, S.
Hisert, K. B.
Cooke, G.
Singh, P.
De Gascun, C.
Gallagher, C. G.
McKone, E. F.
IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (SUPPL 10) : 303 - 304
[7] Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
de Boer, Kaissa
Vandemheen, Katherine L.
Tullis, Elizabeth
Doucette, Steve
Fergusson, Dean
Freitag, Andreas
Paterson, Nigel
Jackson, Mary
Lougheed, M. Diane
Kumar, Vijay
Aaron, Shawn D.
THORAX, 2011, 66 (08) : 680 - 685
[8] MICRONUTRIENT STATUS DURING ACUTE PULMONARY EXACERBATION IN ADULT CYSTIC FIBROSIS
Alvarez, J. A.
Mazer, L. M.
Hebbar, G.
Frediani, J. K.
Benton, S. M.
Grossmann, R. E.
Combs, G. F.
Tangpricha, V
Ziegler, T. R.
PEDIATRIC PULMONOLOGY, 2013, 48 : 403 - 403
[9] CARDIOPULMONARY EXERCISE TEST IN CYSTIC FIBROSIS ADULT PATIENTS WITH NORMAL SPIROMETRY
Zanardelli, M.
Pizzamiglio, G.
Pierini, A.
Ruggiero, D.
Airoldi, A.
Di Pasquale, M.
Blasi, F.
PEDIATRIC PULMONOLOGY, 2011, : 342 - 342
[10] Establishing Criteria For Acute Pulmonary Exacerbation Based On Severity Score In Adult Cystic Fibrosis Patients
Kanchustambham, V.
Wooldridge, J.
Pendleton, G.
Nayak, R. P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189

← 1 2 3 4 5 →